Achieve Life Sciences Inc... (ACHV)
Achieve Life Sciences Statistics
Share Statistics
Achieve Life Sciences has 34.39M shares outstanding. The number of shares has increased by 1% in one year.
| Shares Outstanding | 34.39M |
| Shares Change (YoY) | 1% |
| Shares Change (QoQ) | 0.86% |
| Owned by Institutions (%) | 50.95% |
| Shares Floating | 28.01M |
| Failed to Deliver (FTD) Shares | 793 |
| FTD / Avg. Volume | 0.37% |
Short Selling Information
The latest short interest is 3.15M, so 9.08% of the outstanding shares have been sold short.
| Short Interest | 3.15M |
| Short % of Shares Out | 9.08% |
| Short % of Float | 11.24% |
| Short Ratio (days to cover) | 19.41 |
Valuation Ratios
The PE ratio is -2.83 and the forward PE ratio is -3.59. Achieve Life Sciences's PEG ratio is 0.16.
| PE Ratio | -2.83 |
| Forward PE | -3.59 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | 5.4 |
| P/FCF Ratio | -3.79 |
| PEG Ratio | 0.16 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Achieve Life Sciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.46, with a Debt / Equity ratio of 0.48.
| Current Ratio | 5.46 |
| Quick Ratio | 5.46 |
| Debt / Equity | 0.48 |
| Debt / EBITDA | - |
| Debt / FCF | -0.33 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1.59M |
| Employee Count | 25 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -50.91% in the last 52 weeks. The beta is 1.59, so Achieve Life Sciences's price volatility has been higher than the market average.
| Beta | 1.59 |
| 52-Week Price Change | -50.91% |
| 50-Day Moving Average | 2.85 |
| 200-Day Moving Average | 3.99 |
| Relative Strength Index (RSI) | 35.89 |
| Average Volume (20 Days) | 217.2K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | 0 |
| Net Income | -39.83M |
| EBITDA | 0 |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1.24 |
Balance Sheet
The company has 12.75M in cash and 9.96M in debt, giving a net cash position of 2.79M.
| Cash & Cash Equivalents | 12.75M |
| Total Debt | 9.96M |
| Net Cash | 2.79M |
| Retained Earnings | -205.58M |
| Total Assets | 38.63M |
| Working Capital | 29.79M |
Cash Flow
In the last 12 months, operating cash flow was -29.77M and capital expenditures 0, giving a free cash flow of -29.77M.
| Operating Cash Flow | -29.77M |
| Capital Expenditures | 0 |
| Free Cash Flow | -29.77M |
| FCF Per Share | -0.93 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ACHV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for ACHV is $16, which is 644.2% higher than the current price. The consensus rating is "Buy".
| Price Target | $16 |
| Price Target Difference | 644.2% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Stock Splits
The last stock split was on Jul 31, 2020. It was a backward split with a ratio of 1:20.
| Last Split Date | Jul 31, 2020 |
| Split Type | backward |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | -7.18 |
| Piotroski F-Score | 2 |